Related Experiment Videos

[Clinical experience with a hydrolyzed soy formula in infants with protracted enteritis and atopic eczema]

F Donzelli1, L Da Dalt, A Schiavon

  • 1Dipartimento di Pediatria, Università di Padova, Italia.

Insights

This study found that Pregomin, a soy and beef hydrolysate formula, effectively improved growth and reduced symptoms in infants with enteritis and atopic eczema. It did not cause allergic sensitization to soy protein in infants not previously exposed.

Area of Science:

  • Pediatric Gastroenterology
  • Allergology
  • Clinical Nutrition

Context:

  • Infants with protracted enteritis and atopic eczema often face nutritional challenges and potential food allergies.
  • Hydrolyzed protein formulas are used to manage these conditions, but their potential for causing sensitization requires evaluation.

Purpose:

  • To assess the efficacy and safety of a lactose-free soy and beef hydrolysate formula (Pregomin) in infants with protracted enteritis and atopic eczema.
  • To determine if Pregomin induces allergic sensitization to intact soy protein through oral provocation testing.

Summary:

  • Pregomin administration led to catch-up growth and improved laboratory markers in infants with enteritis.
  • Infants with atopic eczema showed clinical improvement and negative allergic tests after Pregomin treatment.
  • Oral provocation tests with intact soy protein revealed sensitization only in infants with prior soy protein exposure, suggesting Pregomin is non-allergenic for naive infants.

Impact:

  • Pregomin demonstrates efficacy in both gastroenterological and allergological aspects for affected infants.
  • The formula appears safe and non-allergenic, particularly for infants without prior soy exposure.
  • These findings support the use of Pregomin in managing specific pediatric gastrointestinal and allergic conditions.

Related Concept Videos